50 Best Peptides

This website is for informational purposes only and does not constitute medical advice. Read disclaimer

#58

Deslorelin

Reproductive HealthSuprelorinOvuplantDeslorelin Acetate

A potent synthetic GnRH agonist primarily used in veterinary medicine as a subcutaneous implant for reproductive control in animals, with limited investigational use in humans.

Share:

Overview

Deslorelin is a synthetic nonapeptide analog of gonadotropin-releasing hormone (GnRH) that incorporates a D-tryptophan substitution at position 6 and an ethylamide modification at the C-terminus. These structural modifications confer enhanced potency (approximately 10-144 times more potent than native GnRH, depending on the assay) and increased resistance to enzymatic degradation, resulting in a prolonged duration of action.

Deslorelin is primarily known for its veterinary applications, particularly in the form of subcutaneous implants. The Suprelorin implant is widely used in veterinary medicine for chemical castration and reproductive control in dogs, cats, ferrets, and various wildlife species. The implant provides sustained release of deslorelin over 6-12 months (depending on the formulation), producing prolonged suppression of the reproductive axis after an initial stimulatory phase. This makes it a reversible alternative to surgical castration for population management and behavioral modification.

In equine medicine, deslorelin (marketed as Ovuplant) is used as a short-acting implant to induce ovulation in mares for breeding management. The drug triggers an LH surge that causes ovulation within 36-48 hours, allowing precise timing of natural breeding or artificial insemination.

In human medicine, deslorelin has been investigated but has not achieved the same widespread clinical adoption as other GnRH agonists like leuprolide or triptorelin. Early clinical trials explored its use for prostate cancer and endometriosis, and some research evaluated an intranasal formulation. However, the availability of other well-established GnRH agonists with extensive clinical data has limited deslorelin's development path in human therapeutics.

Research Uses & Applications

  • Chemical castration and reproductive suppression in companion animals (dogs, cats, ferrets)
  • Ovulation induction in mares for breeding management
  • Wildlife population management and fertility control
  • Investigational treatment for prostate cancer in humans
  • Research into sustained-release GnRH agonist delivery systems
  • Veterinary behavioral modification through hormone suppression

Key Research Findings

  • Veterinary studies confirmed Suprelorin implants achieve effective reproductive suppression in male dogs for 6-12 months with full reversibility.
  • Research in equine reproduction demonstrated Ovuplant induces ovulation within 48 hours in over 85% of treated mares.
  • Studies in exotic and wildlife species showed deslorelin implants effectively suppress reproduction in zoo animals including big cats, primates, and marsupials.
  • Early human clinical trials suggested deslorelin effectively suppresses testosterone to castrate levels in prostate cancer patients.
  • Comparative pharmacology studies showed deslorelin has one of the highest GnRH receptor binding affinities among synthetic analogs.

Risks & Side Effects

  • Initial flare effect causes transient increase in sex hormones before suppression occurs.
  • Implant site reactions including swelling, inflammation, and rarely migration or fragmentation.
  • In female animals, the initial stimulatory phase can induce estrus and ovulation before suppression begins.
  • Reversibility may be incomplete in some individual animals, particularly with prolonged use.
  • Limited human safety data compared to other GnRH agonists used in clinical medicine.

Administration

In veterinary medicine, administered as a subcutaneous implant (4.7 mg or 9.4 mg Suprelorin implant) placed between the shoulder blades. In equine use, the Ovuplant (2.1 mg deslorelin) is implanted subcutaneously in the neck. Human investigational use has involved subcutaneous injection or intranasal administration. Implant duration of action varies by formulation (6-12 months for Suprelorin).

Legal Status

Approved for veterinary use in many countries (Suprelorin, Ovuplant). Not FDA-approved for human use. Used off-label in various wildlife and zoo animal species. Available as a research chemical from specialized suppliers. Not a controlled substance.

Frequently Asked Questions

What is Deslorelin?

A potent synthetic GnRH agonist primarily used in veterinary medicine as a subcutaneous implant for reproductive control in animals, with limited investigational use in humans.

What are the main uses of Deslorelin?

The primary research applications of Deslorelin include: Chemical castration and reproductive suppression in companion animals (dogs, cats, ferrets); Ovulation induction in mares for breeding management; Wildlife population management and fertility control; Investigational treatment for prostate cancer in humans; Research into sustained-release GnRH agonist delivery systems; Veterinary behavioral modification through hormone suppression.

What are the risks and side effects of Deslorelin?

Documented risks and side effects include: Initial flare effect causes transient increase in sex hormones before suppression occurs.; Implant site reactions including swelling, inflammation, and rarely migration or fragmentation.; In female animals, the initial stimulatory phase can induce estrus and ovulation before suppression begins.; Reversibility may be incomplete in some individual animals, particularly with prolonged use.; Limited human safety data compared to other GnRH agonists used in clinical medicine.. Always consult a healthcare professional before considering any peptide.

Is Deslorelin legal?

Approved for veterinary use in many countries (Suprelorin, Ovuplant). Not FDA-approved for human use. Used off-label in various wildlife and zoo animal species. Available as a research chemical from specialized suppliers. Not a controlled substance.

How is Deslorelin administered?

In veterinary medicine, administered as a subcutaneous implant (4.7 mg or 9.4 mg Suprelorin implant) placed between the shoulder blades. In equine use, the Ovuplant (2.1 mg deslorelin) is implanted subcutaneously in the neck. Human investigational use has involved subcutaneous injection or intranasal administration. Implant duration of action varies by formulation (6-12 months for Suprelorin).

Related Peptides

#23

Kisspeptin-10

Reproductive Health

#28

Oxytocin

Reproductive Health

#54

Gonadorelin

Reproductive Health

#55

Triptorelin

Reproductive Health

Stay Updated on Peptide Research

Get the latest peptide research news and updates delivered to your inbox.

Official Store

Experience Peptides on Your Skin

Shop our curated collection of peptide-infused skincare — Copper Peptide serums, anti-aging treatments, hydrogel patches, and more.

Shop Peptide Skincare

Important Disclaimer

The information on this page is for educational and informational purposes only. It is not intended as medical advice. Always consult a qualified healthcare professional before considering any peptide or supplement. 50 Best Limited does not endorse, recommend, or promote the use of any peptide for self-administration. Read our full disclaimer.

← #57 Alarelin#59 Leuprolide →